|
YWHAH expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.67749999966527E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.85100000005267E-06 |
| Normal-vs-Stage2 |
6.396100E-04 |
| Normal-vs-Stage3 |
1.496150E-03 |
| Normal-vs-Stage4 |
4.821200E-01 |
| Stage1-vs-Stage2 |
9.314200E-01 |
| Stage1-vs-Stage3 |
7.367000E-01 |
| Stage1-vs-Stage4 |
5.558500E-02 |
| Stage2-vs-Stage3 |
8.446800E-01 |
| Stage2-vs-Stage4 |
4.076300E-02 |
| Stage3-vs-Stage4 |
8.746500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.42339999997798E-06 |
| Normal-vs-AfricanAmerican |
3.05270000000579E-06 |
| Normal-vs-Asian |
5.691200E-01 |
| Caucasian-vs-AfricanAmerican |
7.501800E-01 |
| Caucasian-vs-Asian |
3.111200E-01 |
| AfricanAmerican-vs-Asian |
1.872020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.74089999977123E-07 |
| Normal-vs-Female |
1.043250E-03 |
| Male-vs-Female |
1.824430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.499940E-02 |
| Normal-vs-Extreme_Weight |
1.58445999999257E-05 |
| Normal-vs-Obese |
6.03030000045912E-07 |
| Normal-vs-Extreme_Obese |
6.594000E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.326400E-02 |
| Normal_Weight-vs-Obese |
3.341600E-03 |
| Normal_Weight-vs-Extreme_Obese |
8.142600E-01 |
| Extreme_Weight-vs-Obese |
4.308200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.595800E-01 |
| Obese-vs-Extreme_Obese |
1.729840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.357900E-02 |
| Normal-vs-Age(41-60Yrs) |
5.3462000049187E-08 |
| Normal-vs-Age(61-80Yrs) |
2.09889999999158E-05 |
| Normal-vs-Age(81-100Yrs) |
1.716200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.392800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.719600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.482200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.466300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.321600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.779450E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.27779997483435E-09 |
| Normal-VS-Type2 PRCC |
1.117840E-02 |
| Normal-VS-KIRP CIMP |
3.105600E-01 |
| Normal-VS-Unclassified PRCC |
5.765300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.634110E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.833760E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.492020E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.666000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.705450E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.272400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.282000E-03 |
| Normal-vs-N1 |
2.694100E-02 |
| Normal-vs-N2 |
2.406800E-01 |
| N0-vs-N1 |
6.544000E-01 |
| N0-vs-N2 |
8.008800E-01 |
| N1-vs-N2 |
9.626800E-01 |
|
|
